IL-8 May Be the Target of Arsenic in Human Breast Milk

Background and Aims: The critical aim of this study was to evaluate the effects of breast-milk contamination with Nickel and Arsenic, as well as aflatoxin M1 (AFM1) on the milk levels of IL-6 and IL-8. Materials and Methods: Breast milk was collected from 76 mothers on the 30th day post-parturition and milk levels of AFM1, Nickel, Arsenic, IL-6 and IL-8 were evaluated. Results: The results showed 8 and 29 out of 76 collected samples being contaminated with AFM1, Nickel and Arsenic, respectively. Levels of IL-6 and IL-8 in the milk samples did not differ in AFM1 and Nickel and Arsenic contaminated milk compared with the normal controls (non-contaminated milks). There was a moderate positive relation between milk levels of IL-8 and Arsenic. Conclusions: Although AFM1, Nickel and Arsenic are the inducers of cytokine production; they are unable to induce secretion of IL-6 in breast milk. Arsenic can be a trigger of IL-8, which is a strong chemoattract for neutrophils. Thus, it appears that Arsenic may induce an inflammation in milk in IL-8 dependent manner.

Download Full-text

Detection of Aflatoxin M1 in Human Breast Milk and Raw Cow's Milk in Istanbul, Turkey

Journal of Food Protection ◽

10.4315/0362-028x-72.4.885 ◽

2009 ◽

Vol 72 (4) ◽

pp. 885-889 ◽

Cited By ~ 32

Author(s):

YAŞAR KESKIN ◽

RUHTAN BAŞKAYA ◽

SEHER KARSLI ◽

TÜRKAN YURDUN ◽

OĞUZ ÖZYARAL

Keyword(s):

Breast Milk ◽

High Performance ◽

Aflatoxin M1 ◽

Cow’S Milk ◽

Enzyme Linked Immunosorbent Assay ◽

Human Breast Milk ◽

Human Breast ◽

Cow's Milk ◽

Milk Samples ◽

Raw Cow’S Milk

This survey was undertaken to determine the extent of aflatoxin M1 (AFM1) contamination in human breast milk and raw cow's milk in Istanbul, Turkey. Samples of human and raw cow's milk were collected randomly and analyzed for AFM1 using an enzyme-linked immunosorbent assay and high-performance liquid chromatography with fluorescence detection in which the samples were cleaned up with immunoaffinity columns. In this study, AFM1 was detected in 8 (13.1%) of 61 human breast milk samples examined (mean ± SD level, 5.68 ± 0.62 ng/liter; range, 5.10 to 6.90 ng/liter) and 20 (33.3%) of 60 raw cow's milk samples examined (range, 5.40 to 300.20 ng/liter). Five (8.3%) of the positive raw cow's milk samples had AFM1 levels (153.52 ± 100.60 ng/liter; range, 61.20 to 300.20 ng/liter) that were higher than the maximum tolerance limit (0.05 ppb) stipulated by regulations in Turkey and some other countries.

Download Full-text

Aflatoxin M1 in human breast milk samples from Victoria, Australia and Thailand

Food and Chemical Toxicology ◽

10.1016/0278-6915(94)00130-g ◽

1995 ◽

Vol 33 (3) ◽

pp. 173-179 ◽

Cited By ~ 67

Author(s):

H.S. El-Nezami ◽

G. Nicoletti ◽

G.E. Neal ◽

D.C. Donohue ◽

J.T. Ahokas

Keyword(s):

Breast Milk ◽

Aflatoxin M1 ◽

Human Breast Milk ◽

Human Breast ◽

Milk Samples

Download Full-text

Evaluation of Aflatoxin M1 Level in Human Breast Milk samples from Jiroft, South of Iran

Medical Laboratory Journal ◽

10.29252/mlj.14.3.1 ◽

2020 ◽

Vol 14 (3) ◽

pp. 1-6

Author(s):

Mohadeseh Kamali ◽

Ali Kamali ◽

Mehdi Taheri sarvtin ◽

◽

...

Keyword(s):

Breast Milk ◽

Aflatoxin M1 ◽

Human Breast Milk ◽

Human Breast ◽

Milk Samples

Download Full-text

Human Breast Milk Contains Bovine lgG. Relationship to Infant Colic?

PEDIATRICS ◽

10.1542/peds.87.4.439 ◽

1991 ◽

Vol 87 (4) ◽

pp. 439-444

Author(s):

Patrick S. Clyne ◽

Anthony Kulczycki

Keyword(s):

Breast Milk ◽

Human Milk ◽

Milk Protein ◽

Cow’S Milk ◽

Human Breast Milk ◽

Human Breast ◽

Cow's Milk ◽

Milk Samples ◽

Infant Colic ◽

Β Lactoglobulin

Previous studies have suggested that an unidentified cow's milk protein, other than β-lactoglobulin and casein, might play a pathogenetic role in infant colic. Therefore, a radioimmunoassay was used to analyze human breast milk and infant formula samples for the presence of bovine IgG. Milk samples from 88 of the 97 mothers tested contained greater than 0.1 µg/mL of bovine IgG. In a study group of 59 mothers with infants in the colic-prone 2- to 17-week age group, the 29 mothers of colicky infants had higher levels of bovine IgG in their breast milk (median 0.42 µg/mL) than the 30 mothers of noncolicky infants (median 0.32 µg/mL) (P < .02). The highest concentrations of bovine IgG observed in human milk were 8.5 and 8.2 µg/mL. Most cow's milk-based infant formulas contained 0.6 to 6.4 µg/mL of bovine IgG, a concentration comparable with levels found in many human milk samples. The results suggest that appreciable quantities of bovine IgG are commonly present in human milk, that significantly higher levels are present in milk from mothers of colicky infants, and that bovine IgG may possibly be involved in the pathogenesis of infant colic.

Download Full-text

Excretion of Iohexol and Metrizoate in Human Breast Milk

Acta Radiologica ◽

10.1177/028418518702800505 ◽

1987 ◽

Vol 28 (5) ◽

pp. 523-526 ◽

Cited By ~ 15

Author(s):

S. T. Nielsen ◽

I. Matheson ◽

J. N. Rasmussen ◽

K. Skinnemoen ◽

E. Andrew ◽

...

Keyword(s):

Breast Milk ◽

Low Dose ◽

Decay Curve ◽

Human Breast Milk ◽

Human Breast ◽

Blood Samples ◽

Lactating Women ◽

Milk Samples ◽

Slow Decay ◽

Contrast Medium Injection

Six lactating women undergoing contrast media examination had milk and blood taken to determine the rate and extent of excretion of iohexol (Omnipaque) (four mothers) and metrizoate (Isopaque) (two mothers). Blood samples were taken up to 45 minutes and milk samples up to 48 hours after the contrast medium injection. The excretion was low, reaching a maximum at 3 to 6 hours and showing a slow decay curve (t 1/2 = 15 to 108 hours). One mother, who was weaning her baby, showed a different excretion pattern. The amount excreted during 24 hours was about 0.5 per cent of the weight adjusted maternal dose for both iohexol and metrizoate. It is not likely, that such a low dose of poorly absorbed drug would cause any adverse effects in the infant, unless it is hypersensitive to the drug already. The authors consider breast feeding to be acceptable for mothers receiving iohexol or metrizoate.

Download Full-text

Nano-HPLC-HRMS Analysis to Evaluate Leptin Level in Milk Samples: A Pilot Study

Applied Sciences ◽

10.3390/app10176135 ◽

2020 ◽

Vol 10 (17) ◽

pp. 6135

Author(s):

Federica Dal Bello ◽

Enrica Mecarelli ◽

Daniela Gastaldi ◽

Francesco Savino ◽

Claudio Medana

Keyword(s):

Pilot Study ◽

Breast Milk ◽

Infant Formula ◽

Analytical Method ◽

Critical Role ◽

Bovine Milk ◽

Human Breast Milk ◽

Human Breast ◽

Milk Samples ◽

Limit Of Quantitation

Leptin is a 16 kDa lipophilic protein hormone secreted by adipocytes and its most significant function is to inform the brain with negative feedback that regulates food intake. Recently the protein found in human breast milk was related to breast feeding and onset of obesity, and the evidence of a low probability to develop pediatric obesity in children fed with breast milk was also confirmed. Since leptin could have a critical role, its quantitation both in human breast, bovine milk and in infant formula products is interesting. For this reason, we developed an analytical method based on immunoaffinity purification followed by an analysis with nano-High Pressure Liquid Chromatography coupled with High Resolution Mass Spectrometry analyzer (nano-HPLC-HRMS) to identify and quantify leptin in milk samples and performed a pilot study using samples of human breast milk, bovine milk and infant formulas. With an obtained lower limit of quantitation (LLOQ) of 100 ng mL−1 we quantified leptin in human breast milk finding an average of 6.70 ng mL−1. Our results show that leptin was under LLOQ both in bovine milk and in infant formula products. In conclusion, the developed analytical method here described was suitable to quantify leptin in milk samples with a good sensitivity and selectivity, and without the use of radioactive reagents.

Download Full-text

Mycobiome Profiles in Breast Milk from Healthy Women Depend on Mode of Delivery, Geographic Location, and Interaction with Bacteria

Applied and Environmental Microbiology ◽

10.1128/aem.02994-18 ◽

2019 ◽

Vol 85 (9) ◽

Cited By ~ 23

Author(s):

Alba Boix-Amorós ◽

Fernando Puente-Sánchez ◽

Elloise du Toit ◽

Kaisa M. Linderborg ◽

Yumei Zhang ◽

...

Keyword(s):

Breast Milk ◽

Potential Role ◽

Mode Of Delivery ◽

Geographical Location ◽

Geographic Location ◽

Fungal Species ◽

Human Breast Milk ◽

Human Breast ◽

Its1 Region ◽

Milk Samples

ABSTRACTRecent studies report the presence of fungal species in breast milk of healthy mothers, suggesting a potential role in infant mycobiome development. In the present work, we aimed to determine whether the healthy human breast milk mycobiota is influenced by geographical location and mode of delivery, as well as to investigate its interaction with bacterial profiles in the same samples. A total of 80 mature breast milk samples from 4 different countries were analyzed by Illumina sequencing of the internal transcribed spacer 1 (ITS1) region, joining the 18S and 5.8S regions of the fungal rRNA region. Basidiomycota and Ascomycota were found to be the dominant phyla, withMalasseziaandDavidiellabeing the most prevalent genera across countries. A core formed byMalassezia, Davidiella, Sistotrema, andPenicilliumwas shared in the milk samples from the different origins, although specific shifts in mycobiome composition were associated with geographic location and delivery mode. The presence of fungi in the breast milk samples was further confirmed by culture and isolate characterization, and fungal loads were estimated by quantitative PCR (qPCR) targeting the fungal ITS1 region. Cooccurrence network analysis of bacteria and fungi showed complex interactions that were influenced by geographical location, mode of delivery, maternal age, and pregestational body mass index. The presence of a breast milk mycobiome was confirmed in all samples analyzed, regardless of the geographic origin.IMPORTANCEDuring recent years, human breast milk has been documented as a potential source of bacteria for the newborn. Recently, we have reported the presence of fungi in breast milk from healthy mothers. It is well known that environmental and perinatal factors can affect milk bacteria; however, the impact on milk fungi is still unknown. The current report describes fungal communities (mycobiota) in breast milk samples across different geographic locations and the influence of the mode of delivery. We also provide novel insights on bacterium-fungus interactions, taking into account environmental and perinatal factors. We identified a core of four genera shared across locations, consisting ofMalassezia, Davidiella, Sistotrema, andPenicillium, which have been reported to be present in the infant gut. Our data confirm the presence of fungi in breast milk across continents and support the potential role of breast milk in the initial seeding of fungal species in the infant gut.

Download Full-text

Concentration and Prevalence of Aflatoxin M1 in Human Breast Milk in Iran: Systematic Review, Meta-Analysis, and Carcinogenic Risk Assessment: A Review

Journal of Food Protection ◽

10.4315/0362-028x.jfp-18-367 ◽

2019 ◽

Vol 82 (5) ◽

pp. 785-795 ◽

Cited By ~ 22

Author(s):

YADOLAH FAKHRI ◽

RAHEB GHORBANI ◽

MAHMOUD TAGHAVI ◽

HASSAN KERAMATI ◽

NAZAK AMANIDAZ ◽

...

Keyword(s):

Systematic Review ◽

Breast Milk ◽

Meta Analysis ◽

Hazard Index ◽

Carcinogenic Risk ◽

Aflatoxin M1 ◽

Human Breast Milk ◽

Human Breast ◽

Male And Female ◽

The Mean

ABSTRACTThis meta-analysis was designed to review the published reports regarding the concentration and/or prevalence of aflatoxin M1 (AFM1) in human breast milk in Iran. The carcinogenic risk for Iranian infants consuming this milk was estimated with the hazard index. The PubMed and Scopus databases and the Scientific Information Database were screened for relevant studies between 1995 and 2017, and 11 of the 112 collected studies were included in the systematic review and meta-analysis. The mean (95% confidence interval) concentration of AFM1 was 5.85 ng/L (4.54 to 7.15 ng/L), which was lower than the European Union standard (25 ng/L). The mean prevalence of AFM1 in breast milk in Iran was 42% (11 to 77%). The estimated daily intakes for male and female infants were 0.02 to 5.57 ng/kg and 0.02 to 3.68 ng/kg of body weight per day, respectively. The rank order of estimated daily intake for both male and female infants according to age was 1 week > 1 month > 6 months > 12 months. The hazard index for all age groups of infants in all provinces in Iran was less than 1. Therefore, infants in Iran were not considered at carcinogenic risk from AFM1 in human breast milk.

Download Full-text